First Canadian Place
Suite 3400 100 King Street West
Toronto, ON M5X 1A4
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 17
|Dr. Raza Bokhari M.B.A., M.D., MBA||Exec. Chairman & CEO||1||N/A||1968|
|Mr. Anthony John Durkacz||Founder & Director||N/A||N/A||1976|
|Mr. Donal Carroll CPA||Chief Financial Officer||58.67k||N/A||1977|
|Dr. Sara May Ph.D.||Sr. VP||N/A||N/A||N/A|
|Dr. Sandra R. Lottes||VP & Head of Clinical Research of FSD BioSciences, Inc||N/A||N/A||N/A|
|Ms. Maryann Adesso||Chief of Staff||N/A||N/A||N/A|
|Dr. Edward J. Brennan Jr., F.A.C.S., M.D., FACS||Pres of FSD BioSciences, Inc||N/A||N/A||N/A|
FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for central nervous system disorders and autoimmune diseases of the skin, GI tract, and musculoskeletal system, such as chronic pain. FSD Pharma Inc. has strategic alliance agreements with SciCann Therapeutics Inc., CannTab Therapeutics, and Solarvest BioEnergy Inc. The company was founded in 1998 and is headquartered in Toronto, Canada.
FSD Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.